March 20, 2020
Impact of corona virus (COVID-19) on Targovax’s operations
Media
March 17, 2020
Orexo presents sales potential of the pharmaceutical pipeline and digital therapies during the Capital Markets Day
March 12, 2020
GenSight Biologics Reports Full Year 2019 Financial Results and provides an Outlook on 2020
March 12, 2020
Invitation to attend Orexo´s Capital Markets Day via teleconference
March 11, 2020
Targovax ASA: Fourth quarter 2019 results
March 11, 2020
Targovax ASA: Annual Report 2019
March 09, 2020
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy
March 04, 2020
Fusion Pharmaceuticals Announces Appointment of Steven Gannon to Board of Directors
March 03, 2020
GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ™) Phase III trials at the 46th annual meeting of NANOS
March 03, 2020
Targovax announces completed enrollment in the ONCOS-102 trial in anti-PD1 refractory melanoma
